Joshua Makower - Net Worth and Insider Trading

Joshua Makower Net Worth

The estimated net worth of Joshua Makower is at least $441 Million dollars as of 2024-12-03. Joshua Makower is the 10% Owner of Mirum Pharmaceuticals Inc and owns about 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $191 Million. Joshua Makower is the 10% Owner of Monte Rosa Therapeutics Inc and owns about 7,692,298 shares of Monte Rosa Therapeutics Inc (GLUE) stock worth over $76 Million. Joshua Makower is also the 10% Owner of AVEO Pharmaceuticals Inc and owns about 3,952,958 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $59 Million. Besides these, Joshua Makower also holds Akouos Inc (AKUS) , Ardelyx Inc (ARDX) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Achaogen Inc (AKAOQ) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) , ARCA biopharma Inc (ABIO) . Details can be seen in Joshua Makower's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joshua Makower has not made any transactions after 2021-06-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joshua Makower

To

Joshua Makower Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joshua Makower owns 31 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Inozyme Pharma Inc (INZY) among others .

Click here to see the complete history of Joshua Makower’s form 4 insider trades.

Insider Ownership Summary of Joshua Makower

Ticker Comapny Transaction Date Type of Owner
EAR Eargo Inc 2020-10-20 director & 10 percent owner
MTCR Metacrine Inc 2020-09-18 10 percent owner
INZY Inozyme Pharma Inc 2020-07-28 10 percent owner
LIMIT LIMIT 2020-07-24 10 percent owner
LIMIT LIMIT 2020-07-23 10 percent owner
LIMIT LIMIT 2020-07-09 10 percent owner
LIMIT LIMIT 2020-06-30 10 percent owner
LIMIT LIMIT 2020-06-19 10 percent owner
LIMIT LIMIT 2020-04-03 10 percent owner
LIMIT LIMIT 2020-01-29 10 percent owner
LIMIT LIMIT 2020-12-04 10 percent owner
LIMIT LIMIT 2016-07-18 10 percent owner
LIMIT LIMIT 2019-07-22 10 percent owner
LIMIT LIMIT 2019-06-07 10 percent owner
LIMIT LIMIT 2018-12-07 10 percent owner
LIMIT LIMIT 2021-03-16 10 percent owner
LIMIT LIMIT 2018-03-09 10 percent owner
LIMIT LIMIT 2018-02-26 10 percent owner
LIMIT LIMIT 2016-12-19 10 percent owner
LIMIT LIMIT 2003-07-01 director
LIMIT LIMIT 2021-03-15 10 percent owner
LIMIT LIMIT 2018-12-07 10 percent owner
LIMIT LIMIT 2021-04-08 10 percent owner
LIMIT LIMIT 2021-01-01 10 percent owner
LIMIT LIMIT 2021-06-24 10 percent owner
LIMIT LIMIT 2020-12-09 10 percent owner
LIMIT LIMIT 2021-07-29 director & 10 percent owner
LIMIT LIMIT 2021-07-21 10 percent owner
LIMIT LIMIT 2021-06-28 10 percent owner
LIMIT LIMIT 2018-01-19 10 percent owner
LIMIT LIMIT 2021-07-21 10 percent owner

Joshua Makower Latest Holdings Summary

Joshua Makower currently owns a total of 14 stocks. Among these stocks, Joshua Makower owns 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) as of July 22, 2019, with a value of $191 Million and a weighting of 43.28%. Joshua Makower owns 7,692,298 shares of Monte Rosa Therapeutics Inc (GLUE) as of June 28, 2021, with a value of $76 Million and a weighting of 17.2%. Joshua Makower also owns 3,952,958 shares of AVEO Pharmaceuticals Inc (AVEO) as of June 19, 2020, with a value of $59 Million and a weighting of 13.45%. The other 11 stocks Akouos Inc (AKUS) , Ardelyx Inc (ARDX) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Achaogen Inc (AKAOQ) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) , ARCA biopharma Inc (ABIO) have a combined weighting of 26.08% among all his current holdings.

Latest Holdings of Joshua Makower

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MIRM Mirum Pharmaceuticals Inc 2019-07-22 4,186,243 45.59 190,829,887
GLUE Monte Rosa Therapeutics Inc 2021-06-28 7,692,298 9.86 75,846,058
AVEO AVEO Pharmaceuticals Inc 2020-06-19 3,952,958 15.00 59,294,370
AKUS Akouos Inc 2020-06-30 4,294,207 13.29 57,070,011
ARDX Ardelyx Inc 2016-07-18 5,331,039 5.50 29,320,715
TRVI Trevi Therapeutics Inc 2020-04-03 5,937,998 2.78 16,507,634
INZY Inozyme Pharma Inc 2020-07-28 2,437,689 2.62 6,386,745
MRKR Marker Therapeutics Inc 2021-03-16 1,071,429 3.44 3,685,716
RGLS Regulus Therapeutics Inc 2020-12-04 645,106 1.63 1,051,523
EAR Eargo Inc 2020-10-20 326,001 2.57 837,823
AKAOQ Achaogen Inc 2016-12-19 5,215,128 0.03 130,378
MTCR Metacrine Inc 2020-09-18 3,060,527 0.00 4,285
GNCAQ Genocea Biosciences Inc 2020-07-24 10,376,936 0.00 0
ABIO ARCA biopharma Inc 2018-02-26 0 25.50 0

Holding Weightings of Joshua Makower


Joshua Makower Form 4 Trading Tracker

According to the SEC Form 4 filings, Joshua Makower has made a total of 0 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 450,000 shares on July 22, 2019, which cost Joshua Makower around $7 Million.

According to the SEC Form 4 filings, Joshua Makower has made a total of 1 transactions in Monte Rosa Therapeutics Inc (GLUE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Monte Rosa Therapeutics Inc is the acquisition of 1,050,000 shares on June 28, 2021, which cost Joshua Makower around $20 Million.

According to the SEC Form 4 filings, Joshua Makower has made a total of 1 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in AVEO Pharmaceuticals Inc is the acquisition of 1,428,571 shares on June 19, 2020, which cost Joshua Makower around $8 Million.

More details on Joshua Makower's insider transactions can be found in the Insider Trading History of Joshua Makower table.

Insider Trading History of Joshua Makower

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joshua Makower Trading Performance

GuruFocus tracks the stock performance after each of Joshua Makower's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua Makower is 4.83%. GuruFocus also compares Joshua Makower's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua Makower within 3 months outperforms 15 times out of 32 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joshua Makower's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joshua Makower

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 32 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.27 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.9 LIMIT LIMIT LIMIT LIMIT LIMIT

Joshua Makower Ownership Network

Ownership Network List of Joshua Makower

No Data

Ownership Network Relation of Joshua Makower

Insider Network Chart

Joshua Makower Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Joshua Makower is the director & 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

Over the past 18 months, Joshua Makower made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,514 shares made by William Brownie , a net sale of 19 shares made by Adam Laponis , and a net sale of 3 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,536 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,536 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eargo Inc Insider Transactions

No Available Data

Joshua Makower Mailing Address

Above is the net worth, insider trading, and ownership report for Joshua Makower. You might contact Joshua Makower via mailing address: 1212 Terra Bella Avenue, Mountain View Ca 94043.

Discussions on Joshua Makower

No discussions yet.